The adrenergic system in cardiovascular physiology and pathophysiology

Cardiovascular diseases pose an enormous clinical challenge, remaining the most common cause of death in the world. ß-adrenoceptors play an important role on cardiac, vascular and/or endothelial function at a cellular level with relevant applications in several cardiovascular diseases, such as heart...

Full description

Saved in:
Bibliographic Details
Main Author: Giuseppe Rengo (auth)
Format: Book Chapter
Published: Frontiers Media SA 2015
Subjects:
Online Access:Get Fullteks
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 03402naaaa2200313uu 4500
001 doab_20_500_12854_40169
005 20210211
020 |a 978-2-88919-398-1 
020 |a 9782889193981 
024 7 |a 10.3389/978-2-88919-398-1  |c doi 
041 0 |a English 
042 |a dc 
100 1 |a Giuseppe Rengo  |4 auth 
245 1 0 |a The adrenergic system in cardiovascular physiology and pathophysiology 
260 |b Frontiers Media SA  |c 2015 
300 |a 1 electronic resource (85 p.) 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Cardiovascular diseases pose an enormous clinical challenge, remaining the most common cause of death in the world. ß-adrenoceptors play an important role on cardiac, vascular and/or endothelial function at a cellular level with relevant applications in several cardiovascular diseases, such as heart failure and hypertension. G protein- coupled receptors (GPCRs), including ß-adrenergic receptors, constitute the most ubiquitous superfamily of plasma membrane receptors and represent the single most important type of therapeutic drug target. Sympathetic nervous system hyperactivity, which characterizes several cardiovascular diseases, such as heart failure and hypertension, as well as physiological ageing, has been proved to exert in the long-term detrimental effects in a wide range of cardiovascular diseases. Acutely, sympathetic hyperactivity represents the response to an insult to the myocardium, aiming to compensate for decreased cardiac output. This process involves the activation of beta-adrenergic receptors by catecholamine with consequent heart rate and cardiac contractility increase. However, long-term exposure of the heart to elevated norepinephrine and epinephrine levels, originating from sympathetic nerve endings and chromaffin cells of the adrenal gland, results in further progressive deterioration in cardiac structure and function. At the molecular level, sustained sympathetic nervous system hyperactivity is responsible for several alterations including altered beta-adrenergic receptor signaling and function (down-regulation/ desensitization). Moreover, the detrimental effects of catecholamine affect also the function of different cell types including, but not limited to, endothelial cells, fibroblasts and smooth muscle cells. Thus, the success of beta-blocker therapy is due, at least in part, to the protection of the heart and the vasculature from the noxious effects of augmented catecholamine levels. The research topic aimed to support the progress towards understanding the role of sympathetic nervous system under physiological conditions, and the contribution of its hyperactivity in the pathogenesis and progression of cardiovascular diseases. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
653 |a GRK2 
653 |a Beta-adrenoceptors 
653 |a exercise training 
653 |a Heart Failure 
653 |a Sympathetic Nervous System 
653 |a beta-blockers 
653 |a functional recovery 
856 4 0 |a www.oapen.org  |u http://journal.frontiersin.org/researchtopic/1532/the-adrenergic-system-in-cardiovascular-physiology-and-pathophysiology  |7 0  |z Get Fullteks 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/40169  |7 0  |z DOAB: description of the publication